Lab
Fremanor, INC.
Fremanor, INC. was paid $366K by Medicaid between Jan 2018 and Oct 2024, across 32 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 21% of everything it billed.
33Billing provider infoFREMANOR, INC.
VEGA ALTA, PR 00692
VEGA ALTA, PR 00692
33aNPI1306922737assigned 10/27/2006
33bProvider typeClinical Medical Laboratory
28Total paid$366K
24GClaims28,234
24DCodes billed32
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#332 of 777
Median peer was paid$278K
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,156 | $46K | |
| 2019 | 2,850 | $26K | |
| 2020 | 3,176 | $31K | |
| 2021 | 5,267 | $78K | |
| 2022 | 5,570 | $112K | |
| 2023 | 3,168 | $38K | |
| 2024incomplete | 3,047 | $34K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 21% | 1,779 | 1,676 | $75K |
| 84443 | Thyroid stimulating hormone (TSH) | 15% | 3,337 | 3,088 | $53K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 14% | 2,280 | 2,102 | $53K |
| 80061 | Lipid panel | 11% | 3,225 | 2,989 | $42K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 11% | 5,165 | 4,647 | $38K |
| 80053 | Comprehensive metabolic panel | 9.9% | 3,592 | 3,291 | $36K |
| 81000 | 3.3% | 3,858 | 3,558 | $12K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.2% | 1,241 | 1,125 | $12K |
| 86328 | 2.8% | 566 | 534 | $10K | |
| 82274 | 2.2% | 539 | 479 | $8K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.9% | 247 | 200 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 409 | 205 | $5K |
20 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 581 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 38 | $1K |
| 86701 | <1% | 155 | $1K | |
| 84439 | <1% | 146 | $1K | |
| 84436 | <1% | 203 | $1K | |
| 86738 | <1% | 99 | $1K | |
| 84479 | <1% | 157 | $940.59 | |
| 82043 | <1% | 142 | $873.11 | |
| 87088 | <1% | 98 | $809.16 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 70 | $572.81 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 66 | $562.00 |
| 87276 | <1% | 23 | $280.35 | |
| 87275 | <1% | 23 | $280.35 | |
| 86769 | <1% | 14 | $266.00 | |
| 84153 | <1% | 13 | $240.60 | |
| 86592 | <1% | 24 | $95.42 | |
| 85651 | <1% | 14 | $47.23 | |
| 82947 | <1% | 12 | $46.05 | |
| 87899 | <1% | 46 | $35.58 | |
| 87328 | 0% | 72 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOLLAZO, NORMA (ADMINISTRATOR/M.T.)